Physician profile
William B Workman
NPI 1407110257
$3,672.91
in general payments reported to CMS, 2019-2025
35 companies · $39.95 in 2025
The $39.95 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $31.17 · 2021: $455 · 2022: $978 · 2023: $1,403 · 2024: $475 · 2025: $39.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,515 · Travel and Lodging: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,514.75 |
| Travel and Lodging | $403.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $902.66 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Si-Bone, INC. | $403.21 | 2023 | |
| Xeris Pharmaceuticals, INC. | $377.42 | 2021-2023 | Gvoke Hypopen |
| Pfizer INC. | $347.05 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $120.13 | 2022 | |
| Amarin Pharma, INC. | $116.61 | 2019-2021 | |
| Amgen INC. | $112.43 | 2019-2024 | Otezla, Repatha, Prolia |
| Novartis Pharmaceuticals Corporation | $95.33 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $91.40 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $90.96 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Abbvie INC. | $89.50 | 2022-2024 | Vraylar |
| Otsuka America Pharmaceutical, INC. | $79.33 | 2023-2024 | Rexulti |
| Lilly USA, LLC | $79.05 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Daiichi Sankyo INC. | $74.06 | 2019-2023 | Injectafer |
| Abbott Laboratories | $73.68 | 2022-2025 | Freestyle Libre 3 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Workman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.